3D InSight™ Neural Microtissues Production Schedule

InSphero 3D InSight™ Neural Microtissues are perishable items, produced regularly in our bioproduction facilities and shipped directly to laboratories in the United States and Europe, for ready-to-use upon arrival.

Production Schedule | 3D InSight™ Human Neural Microtissues

Plan Your CNS Safety Studies with Confidence 

Access assay-ready 3D InSight™ Human Neural Microtissues through scheduled production runs designed to support predictable study planning and reliable access to human-relevant neural models. 

Choose the configuration that best fits your application: 

Neuron–astrocyte ratio 

  • Balanced model: 50% neurons / 50% astrocytes 
  • Neuron-rich model: 90% neurons / 10% astrocytes 

Plate format 

  • Akura™ 96- or 384-well Spheroid Microplate 
  • Round-bottom ULA 96- or 384-well plate 

Once your order is confirmed, our expert team manages spheroid aggregation, maturation, rigorous quality control, and shipment. Your assay-ready human 3D neural microtissues arrive prepared for scalable neurotoxicity screening and functional CNS safety assessment. 

With scheduled production runs every 4–6 weeks, you can coordinate model availability with your study timelines and plan upcoming screening campaigns with confidence. 

The table below lists the upcoming production schedule for 3D InSight™ Neural Microtissues. The dates apply to all model configurations. 

Order by contacting us; our BD team will reach out to you.  

Month Order By Date Expected Delivery Date
May, 2024
May 31
Jun 11-14
June, 2024
Jun 7
Jun 18-21**
June, 2024
Jun 14
Jun 25-28
June, 2024
Jun 21
Jul 2-5**
June, 2024
Jun 28
Jul 8-12
July, 2024
July 5
Jul 15-19
July, 2024
July 12
Jul 22-16
July, 2024
July 19
Jul 29-Aug 2
July, 2024
July 31
Aug 12-Aug 16
Scroll to Top

Your Success is Our Mission - Get in Touch

Fill in form below to contact our 3D in vitro experts

Sign up for our Newsletter

Get the latest news on 3D in vitro research

View resource

Fill in the form below to view this resource